With the strategy of his fund “The Investment Company of America”, Capital Group manages to beat the market in the long term. On which shares of the US assets administrator.
• Fund of Capital Group has been beating the US stock market for decades
• Large tech values are underweighted
• Careful selection of shares in long -term investment horizon
The billion dollar deal from Oracle and Openai has fueled the concerns about a dangerous AI bubble again. Numerous AI experts have skeptically commented on the collaboration. Gary Marcus, AI expert, who has been warning of a bladder for about two years, even called the deal between Oracle and Openaai “top value of the bladder”.
Furthermore, an investigation of the MIT, about which Fortune reports, reported that 95 percent of the AI pilot projects, despite investing over $ 40 billion in generative AI, hardly any significant income. This feeds the fear that there is a clear gap between the hype about investments and the actual results.
Capital Group fund does not rely on tech giants
The strategy of “The Investment Company of America” could be interesting for investors who therefore want to make themselves a little more independent of the trend topic of AI. The investment vehicle has beaten the S&P 500 index, which reflects the wide US stock market, on a rolling three-year basis. As “Cash” reports, the strategy based at the end of 1933 achieved an annualized return (after fees) of 12.2 percent, while the S&P 500 only came to 11.2 percent.
It is also noteworthy that volatility was lower than that of the overall market. This is also due to the fact that “The Investment Company of America” does not focus on artificial intelligence – the Magnificent Seven (Alphabet, Apple, Amazon, Meta, Microsoft, Nvidia and Tesla) are underweight – but on a selective, careful share selection with a long -term horizon of eight and more years. “We do not rely on individual, large -scale -capitalized companies as the main driver for absolute and relative returns. Broadcom, Eli Lilly, Royal Caribbean, United Rental, carrier global and ge aerospace were our most successful draft horses,” is cited Anita Patel, investment director of Capital Group.
Overlooked stocks
According to the investment expert, there are also two-digit growth rates away from the artificial intelligence of US companies, which are overlooked on the hype theme AI due to the strong market concentration. Among other things, this applies to GE Aerospace. As a leading engine manufacturer, the company should benefit from the high order stock at Boeing and Airbus. In addition, Boeing and Airbus do not produce their planes quickly enough, which is why the engines currently used would have to be waited for more regularly. This secure safe sales in the aftermarket business. In the short term, the share may seem expensive, but in the long term, GE Aerospace is valued cheaply, says Patel.
In addition, the US asset manager relies on Abbott Labs, which is active in the areas of diabetes and cardiovascular diseases. The diabetes area in particular is an important driver and contributed significantly to the margins. “It is another example of a company that is currently being overlooked by the market. Abbott Labs has increased its profits stably and at the same time has not cut its dividends for over 50 years,” said Anita Patel.
More than two thirds of the fund’s assets are invested in Large Caps, but Mid Caps such as carrier global are also included. As one of the world’s leading providers of heating, ventilation and air conditioning systems (HLK), the company is part of an industry whose products have little cyclical volumes fluctuations. Carrier Global also benefits from decarbonization: The technology of the company makes HLK systems more energy-efficient and thus reduce the greenhouse gas emissions of buildings.
Editor finance.net
By the way: Abbott Laboratories and other US shares are even tradable at Finance.net Zero until 11 p.m. (without order fees, plus spreads). Open Depot now for free And secure new customer bonus!
Selected leverage products on Abbott Laboratories
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Abbott Laboratories
The lever must be between 2 and 20
Advertising